Amneal Pharmaceuticals, Inc. (AMRX)
13.81
-0.68
(-4.69%)
USD |
NASDAQ |
Feb 27, 16:00
13.81
0.00 (0.00%)
After-Hours: 05:49
Amneal Pharmaceuticals Research and Development Expense (Annual) : 186.18M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Pfizer Inc. | 10.25B |
| Corcept Therapeutics, Inc. | 254.91M |
| Apellis Pharmaceuticals, Inc. | 295.85M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| BioMarin Pharmaceutical, Inc. | 700.97M |